Surmodics is involved in medical device coatings and in vitro diagnostics. It provides customized coatings for medical devices and chemical components for in vitro diagnostic tests.

Surmodics

CloudFront

ASP.NET Ajax

Thing Schema

DevExpress ASP.NET

Leadfeeder

Engineering

Kevin Burton

Business Management

Kimberly Brastad

Quality

Paul Rohlwing

Human Resources

Teresa Murray

Sales and Support

Thomas Worthington

Marketing and Product

Andrew McCrea

Aneil Kamath

Operations

Brad Cates

Daniel Arnswald

Hal Grey

Gary R. Maharaj

President and Chief Executive Officer

Great Lakes Companies With More Than $10M in Revenue (Top 10K)

Greater Minneapolis-Saint Paul Area Companies With More Than $10M in Revenue

Medical Companies With Less Than $500M in Revenue (Top 10K)

Greater Minneapolis-Saint Paul Area Companies With More Than $1M in Revenue (Top 10K)

Surmodics is a vitro diagnostic company that develops sensitive and reproducible immunoassays.

Eden Prairie

Minnesota

United States

North America

Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Surmodics Non-GAAP EPS of -$0.13 beats by $0.16, revenue of $33.2M beats by $2.8M (SRDX:NASDAQ)

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce Thrombectomy System

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Surmodics, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 23, 2024 8:30 PM	142a698a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 23, 2024 8:30 PM	9e5b46c6
crunchbase trigger	general	Dec 4, 2024 8:54 AM	bab7a549
crunchbase profile	general	Dec 4, 2024 2:54 PM	7846214f
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 3:25 PM	f126d5b6
peers	general	Oct 23, 2024 8:30 PM	cc47cdf2
news basic	general	Oct 23, 2024 8:30 PM	20ea8f17
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SURMODICS

Surmodics

Last Close

39.19

22/11 21:00

Market Cap

600.57M

Beta: -

Volume Today

174.41K

Avg: -